| OAF0204 | Involvement of law enforcement agencies in responding to GBV against LGBTI people and in reducing their vulnerability for better access to healthcare for key populations in the city of Douala | Oral abstract session with live Q&A | F9 |
| OAF0403 | Utilizing individual level data to assess the relationship between prevalent HIV infection and punitive same sex policies and legal barriers across 10 countries in Sub-Saharan Africa | Oral abstract session with live Q&A | F9 |
| PEF1762 | 3-step research on patent monopolies impact on access to essential treatment for HIV patients | E-poster | F8 |
| PEF1763 | Oppositions against abusive patents on medicines by civil society: An effective way to break market monopolies and reduce treatment costs | E-poster | F8 |
| PEF1764 | Promotion of access to medicines: Is compulsory licensing or voluntary licencing the answer? | E-poster | F8 |
| PEF1765 | Countering HIV and hepatitis excessive drug prices in Europe by adopting intellectual property strategies from activists in low- and middle-income countries | E-poster | F8 |
| PEF1766 | Public purchases and HIV in Guatemala, 2018 | E-poster | F8 |
| PEF1767 | Patent Oppositions Academy. A promising community-driven learning initiative to prevent low quality patents on medicines and promote access to treatment | E-poster | F8 |
| PEF1768 | The development of drug pricing principles to strengthen equitable and sustainable access to HIV and HCV prevention and treatment in the U.S. | E-poster | F8 |
| LBPEF58 | The Affordable Care Act and HIV pre-exposure prophylaxis: Regional disparities in qualified health plan coverage and prior authorization requirements, 2018-2020 | E-poster | F7 |